Cargando…

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection

Human cytomegalovirus (HCMV) infection is an important cause of morbidity and mortality in immunocompromised patients and a major etiological factor for congenital birth defects in newborns. Ganciclovir and its pro-drug valganciclovir are the preferred drugs in use today for prophylaxis and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landázuri, Natalia, Gorwood, Jennifer, Terelius, Ylva, Öberg, Fredrik, Yaiw, Koon Chu, Rahbar, Afsar, Söderberg-Nauclér, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619441/ https://www.ncbi.nlm.nih.gov/pubmed/34831300 http://dx.doi.org/10.3390/cells10113072

Ejemplares similares

Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells
por: Mohammad, Abdul-Aleem, et al.
Publicado: (2017)

Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells
por: Yaiw, Koon-Chu, et al.
Publicado: (2021)

Higher Human Cytomegalovirus (HCMV) Specific IgG Antibody Levels in Plasma Samples from Patients with Metastatic Brain Tumors Are Associated with Longer Survival
por: Peredo-Harvey, Inti, et al.
Publicado: (2023)

Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
por: Yaiw, Koon-Chu, et al.
Publicado: (2015)

Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
por: Vasaikar, Suhas, et al.
Publicado: (2018)

High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes
por: Taher, Chato, et al.
Publicado: (2013)

Human Cytomegalovirus (HCMV) induces Human Endogenous Retrovirus (HERV) transcription
por: Assinger, Alice, et al.
Publicado: (2013)

Presence of the Human Cytomegalovirus in Glioblastomas—A Systematic Review
por: Peredo-Harvey, Inti, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
por: Sidharta, P. N., et al.
Publicado: (2015)

High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy
por: Yaiw, Koon-Chu, et al.
Publicado: (2013)

High Prevalence of Human Cytomegalovirus in Brain Metastases of Patients with Primary Breast and Colorectal Cancers()()()
por: Taher, Chato, et al.
Publicado: (2014)

Macitentan: entry-into-humans study with a new endothelin receptor antagonist
por: Sidharta, Patricia N., et al.
Publicado: (2011)

Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival
por: Carlson, Joseph W., et al.
Publicado: (2018)

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity
por: Geisler, Jürgen, et al.
Publicado: (2019)

Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
por: Tynan, Timothy, et al.
Publicado: (2019)

Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls
por: Mohammad, Abdul-Aleem, et al.
Publicado: (2014)

Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
por: Bruderer, Shirin, et al.
Publicado: (2011)

Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
por: Belge, Catharina, et al.
Publicado: (2019)

Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study
por: Rahbar, Afsar, et al.
Publicado: (2012)

High Rate of Cytomegalovirus Detection in Cholestatic Preterm Infants
por: Teng, Jonas, et al.
Publicado: (2021)

Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study
por: Touma, Joel, et al.
Publicado: (2023)

Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept study
por: Feenstra, Rutger G.T., et al.
Publicado: (2023)

Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer
por: Costa, Helena, et al.
Publicado: (2019)

Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus
por: Söderberg-Nauclér, Cecilia
Publicado: (2012)

Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
por: Söderberg-Nauclér, Cecilia
Publicado: (2021)

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia
por: Maffei, Rossana, et al.
Publicado: (2017)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
por: Stragliotto, Giuseppe, et al.
Publicado: (2020)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
por: Pantalone, Mattia Russel, et al.
Publicado: (2022)

Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer()
por: Rådestad, Angelique Flöter, et al.
Publicado: (2018)

Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens—A Novel, Automated Immunohistochemical Staining Protocol
por: Touma, Joel, et al.
Publicado: (2021)

Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes
por: Lepist, Eve-Irene, et al.
Publicado: (2014)

Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells
por: Gatfield, John, et al.
Publicado: (2012)

Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer
por: Rahbar, Afsar, et al.
Publicado: (2020)

Cytomegalovirus infection in brain tumors: A potential new target for therapy?
por: Söderberg-Nauclér, Cecilia, et al.
Publicado: (2012)

Is human cytomegalovirus a target in cancer therapy?
por: Johnsen, John Inge, et al.
Publicado: (2011)

New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
por: Söderberg-Nauclér, Cecilia
Publicado: (2022)

The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross‐species comparison of its cytochrome P450 induction pattern
por: Treiber, Alexander, et al.
Publicado: (2020)

Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology
por: Gredmark-Russ, Sara, et al.
Publicado: (2012)

Human cytomegalovirus infection enhances 5-lipoxygenase and cycloxygenase-2 expression in colorectal cancer
por: Pantalone, Mattia Russel, et al.
Publicado: (2023)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1b9pfjf35jilqpe1cf91s28d5v